Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 October 2025 | Story Lacea Loader

The University of the Free State (UFS) Executive Committee (Exco), Institutional Representative Council (ISRC), and Campus Student Representative Councils (CSRCs) of the three campuses met on 15 October 2025 and reached an agreement regarding the implementation of the phasing out of provisional registration. 
The discussions were held in light of the decision made by the UFS Council on 26 September 2025 to phase out the provisional registration – a decision that led to the recent protest actions on the three campuses the past week. 

In a spirit of working towards a fairer, more equitable, and sustainable financial support system for all academically deserving students, Exco and the student leadership agreed that provisional registration will be phased out over a period of two years (2026-2027). This phased approach allows the university time to assess the risks students are facing with a view to assisting students. This means that from 1 January 2026, all students will be on a fully registered system. 

In recognition of the challenges students face, the outcomes of the meeting reflect the university’s ongoing commitment, and it ensures that all students are supported within a financially sustainable framework. It also reaffirms the university’s commitment to expanding access through enhanced financial support while sustaining the UFS as a national asset for future generations. 

The Exco remains committed to ongoing engagement with student leadership through open dialogue that reflects the university’s values, appreciates the constructive approach taken by the student leadership, and remains dedicated to working collaboratively in the best interest of all students and the broader university community.

News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept